Watch for Continued Liquidation in Shares of Albany Molecular Research (AMRI)
Shares of Albany Molecular Research (NASDAQ:AMRI) traded at a new 52-week low yesterday of $5.40. Approximately 66,000 shares have traded hands yesterday vs. average 30-day volume of 63,000 shares. Albany Molecular Research closed at $5.43, approximately 26.5% below its 50-day moving average of $7.39. SmarTrend will be monitoring shares of AMRI to see if this bearish momentum will continue.
For the record, I've been a bear regarding AMRI. However, at current trading levels it looks like a buy.
That being said, the post that started this thread is merely a copy and paste of a report that offers few insights and little valued added. Too many generalities. Liquidation? The author is throwing darts at the wall. Who is liquidating? If the author could provide that information, then the report might have some credibility. Otherwise, it is a small steaming pile of camel droppings. Sorry to rain on some on your parades.